“GSK delivered another year of excellent performance in 2024, with strong sales and core profit growth driven by accelerating momentum of our specialty medicines portfolio,” Emma ...

It’s been two and a half years since Emma Walmsley took over as CEO of GlaxoSmithKline ... with perhaps the most eye-catching appointment being that of chief scientific officer Hal Barron ...

GSK could double its long-serving CEO Emma Walmsley’s pay packet to £21.6 million ($27.2 million) after admitting its boss's current pay didn’t reward her performance and would put off future ...

GSK boosted Walmsley’s compensation 51% in 2023, owing to the company’s strong sales. GSK recorded £30.3 billion ($40.5 billion) in turnover in 2023, up 3.4% from the previous year.